(They keep reporting that the Q2 bar was set especially low this time but I’m not sure that I buy that since the bar seems to be low every quarter since most companies always beat estimates and this keeps the market climbing. I’ll bet the analysts making these estimates are buying like crazy just before that start of reporting.) Volume was a little below recent averages at just under 9.7 billion.
mon
JULY 27, 2020 / 6:09 pm
Wall Street rises as investors watch stimulus, pandemic and
earnings
DJ: 26,469.89 -182.44 NAS: 10,363.18
-98.24 S&P: 3,215.63
-20.03 7/24
DJ: 26,584.77 +114.88 NAS: 10,536.27 +173.09 S&P: 3,239.41
+23.78 7/27
(Reuters) - Wall Street’s
main indexes closed higher on Monday as investors bet on some of the market’s
most high-profile stocks ahead of earnings reports while they weighed progress
in U.S. government stimulus efforts against rising U.S. COVID-19 cases. Apple Inc (AAPL.O),
Amazon.com Inc (AMZN.O), Facebook Inc (FB.O)
and Alphabet Inc (GOOGL.O), all due to report earnings this
week, were among the top boosters of the S&P 500. The technology-heavy
Nasdaq posted a 1.7% gain, outperforming the S&P and the Dow.
Netflix
(NFLX.O) and Microsoft (MSFT.O)
also gained, noted John
Augustine, chief investment officer at Huntington National Bank in Columbus,
Ohio, who said investors were buying stocks in the group, which fell in recent
sessions. “When all six of them are higher they’ll take markets with
them,” said Augustine, adding that with the exception of Facebook the
so-called FAANG plus M stocks due to report have “a low bar to step over to
beat earnings estimates.”
The
Dow Jones Industrial Average .DJI rose 114.88 points, or 0.43%, to 26,584.77,
the S&P 500 .SPX gained 23.78 points, or 0.74%, to 3,239.41
and the Nasdaq Composite .IXIC added 173.09 points, or 1.67%, to 10,536.27. The
biggest gainers among the S&P’s 11 major sectors were technology .SPLRCT,
up 1.6%, and materials .SPLRCM, up 1.4%, followed by real estate .SPLRCR, up
1.1%. Financials .SPSY, down 1.3%, and
utilities .SPLRCU, down 0.8%, were the only sectors to end the day lower while
energy .SPNY eked out a small gain of 0.2%.
U.S. Senate Republicans
raced to complete details of a $1 trillion coronavirus aid proposal
before enhanced unemployment benefits expire on Friday. The aid proposal, which
could involve a reduction in emergency federal weekly unemployment benefits
from $600 to $200, would then need to be negotiated with Democrats. After the market closed, senate majority
leader Mitch McConnell
said the package would address health, schools and include direct payments to
Americans of $1,200 each.
Some investors have worried whether the package would provide
sufficient support for the economy. These concerns were reflected in gains in
assets viewed as safe havens such as the big growth companies and gold XAU=,
according to Kristina Hooper, Chief Global Market Strategist at Invesco in New
York. “Today’s story is about concerns that the economic
recovery will be slow and halting. That’s from a combination of an
inability to bend the virus curve and what is shaping up to be a small stimulus package that
may not address all the needs being created by this terrible crisis,”
said Hooper. Trillions of dollars in
fiscal and monetary stimulus have been pivotal pushing the S&P 500 closer to its February
record high. It ended Monday’s session 4.3% below the record.
On Monday, as the world confronted the prospect of rising
COVID-19 infections, countries in Asia and Europe imposed new restrictions. In the United States, where infection rates
have climbed since June, two baseball games were canceled due to the virus
while President Donald Trump’s national security adviser Robert O’Brien was the
most senior official to test positive.
Investors kept their eye on earnings, with 189 S&P 500 companies scheduled to report results this week. About 80% of the 130
S&P 500 firms that have reported so far have beaten a low bar of
earnings estimates, according to IBES Refinitiv data. Few expected any major announcement at a
two-day Federal Reserve meeting, but analysts said policymakers were likely to
lay the groundwork for more action later this year.
Moderna
Inc (MRNA.O) shares finished up 9% after U.S. and
company officials said its COVID-19 vaccine may be ready for widespread use by
year-end. The drugmaker
announced it started a trial to demonstrate safety and effectiveness, which
could be the final hurdle prior to regulatory approval.
Advancing issues outnumbered declining ones on the NYSE by a
1.66-to-1 ratio; on Nasdaq, a 1.47-to-1 ratio favored advancers. The S&P 500 posted 19 new 52-week highs
and no new lows; the Nasdaq Composite recorded 64 new highs and 27 new lows.
On U.S. exchanges 9.69 billion shares changed hands compared with the 10.6 billion
average for the last 20 sessions.
No comments:
Post a Comment